KRAS Inhibitors Market 2025 to 2034
KRAS Inhibitors Market 2025 to 2034
KRAS Inhibitors Market (By Cancer Type: Lung Cancer, Pancreatic Cancer, Colorectal Cancer, Others; By End-Use: Clinic Laboratories, Cancer Diagnostic Centers, Hospitals, Cancer Research Institutes, Academic Institutions, Others; By Region: North America, Latin America, Europe, Asia-Pacific, Middle and East Africa) Industry Size, Share, Growth, Trends 2025 to 2034.
Customisation Request
Revenue, 2025
USD 118.26 Bn
Forecast Year, 2034
USD 182.36 Bn
CAGR, 2025 - 2034
4.93%
Report Coverage
Worldwide
Published By
Saurabh Bidwai
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
The global KRAS inhibitors market, valued at USD 118.26 billion in 2025, is expected to reach USD 182.36 billion by 2034, growing at a CAGR of 4.93%, driven by rising cancer prevalence, innovative therapies, and targeted drug development.
KRAS Inhibitors Market Size Analysis
KRAS Inhibitors Market Size By Cancer Type 2025 to 2034 (USD Billion)
| Cancer Type | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Lung Cancer | 9.72 | 10.18 | 10.65 | 11.23 | 11.79 | 12.41 | 12.97 | 13.70 | 14.45 | 15.11 |
| Pancreatic Cancer | 62.35 | 65.28 | 68.53 | 71.94 | 75.42 | 79.13 | 83.14 | 87.13 | 91.46 | 95.78 |
| Colorectal Cancer | 27.28 | 28.72 | 30.12 | 31.61 | 33.19 | 34.75 | 36.51 | 38.26 | 40.08 | 42.20 |
| Others | 18.91 | 19.91 | 20.90 | 21.86 | 22.97 | 24.14 | 25.24 | 26.54 | 27.80 | 29.26 |
KRAS Inhibitors Market Size By End-Use 2025 to 2034 (USD Billion)
| End-Use | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Clinic Laboratories | 9.18 | 9.66 | 10.15 | 10.69 | 11.16 | 11.79 | 12.44 | 13.01 | 13.60 | 14.21 |
| Cancer Diagnostic Centers | 58.85 | 61.78 | 64.78 | 67.98 | 71.40 | 74.82 | 78.53 | 82.23 | 86.24 | 90.55 |
| Hospitals | 25.75 | 27.03 | 28.38 | 29.71 | 31.21 | 32.71 | 34.25 | 36.07 | 38.00 | 39.91 |
| Cancer Research Institutes | 17.85 | 18.66 | 19.61 | 20.61 | 21.56 | 22.66 | 23.72 | 24.97 | 26.14 | 27.41 |
| Academic Institutions | 3.32 | 3.48 | 3.65 | 3.83 | 4.04 | 4.26 | 4.50 | 4.73 | 4.97 | 5.22 |
| Others | 3.32 | 3.47 | 3.63 | 3.81 | 3.99 | 4.19 | 4.42 | 4.63 | 4.84 | 5.07 |
KRAS Inhibitors Market Size By Region 2025 to 2034 (USD Billion)
| Region | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| North America | 9.44 | 9.88 | 10.41 | 10.93 | 11.52 | 12.03 | 12.71 | 13.40 | 14.02 | 14.66 |
| Europe | 60.55 | 63.56 | 66.72 | 69.95 | 73.40 | 77.11 | 80.79 | 84.80 | 88.79 | 93.12 |
| Asia Pacific | 26.49 | 27.78 | 29.16 | 30.61 | 32.05 | 33.66 | 35.28 | 36.96 | 38.91 | 41.00 |
| Latin America | 18.37 | 19.28 | 20.16 | 21.18 | 22.25 | 23.27 | 24.47 | 25.61 | 26.96 | 28.22 |
| Middle East and Africa | 3.41 | 3.58 | 3.76 | 3.95 | 4.14 | 4.36 | 4.60 | 4.85 | 5.11 | 5.36 |
KRAS Inhibitors Market Size to Attain USD 182.36 Billion by 2034
The global kras inhibitors market size was estimated at USD 118.26 billion in 2025 and is projected to be worth around USD 182.36 billion by 2034 a CAGR of 4.93%.
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
